Delivery Order SPE2DB20D3103-SPE2DB22FP9H5
Award Date
9/19/22
Potential Completion Date
9/20/22
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,153.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, which are used to treat certain types of chronic anemia. The contract is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. The contract is not designated as a set-aside award, indicating it...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,415.26 contract is for the provision of the medication Deferasirox 500 mg tablets for suspension, with a completion date of February 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a total ceiling value of $2,169.38 and a period of performance through February 6, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,786.52, is for the delivery of 4,567,105,531 units of the medication Deferasirox 500 mg tablets for suspension. This is a firm fixed-price delivery order contract, with a period of performance running through January 31, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,425.17 Firm Fixed Price Delivery Order contract is for the supply of 4567057652 - DEFERASIROX 360 MG TABLET 30S, with a performance period ending on January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Deferasirox 360 mg tablets. The contract has a ceiling value of $12,897.11 and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a larger parent organization. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,583.96, is a Delivery Order for the supply of 4,566,199 units of the drug Deferasirox 360 mg Tablet, packaged in 30s. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Deferasirox 500 mg Tablets for Suspension. The contract has a ceiling value of $5,629.92 and an ultimate completion date of September 13, 2024. This is a Firm Fixed Price contract for the delivery of this pharmaceutical product. The award is not associated with any set-aside designation. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen...
This federal contract award is for the delivery of 50 tablets of the pharmaceutical drug deferiprone, 1,000 mg per tablet, with a 3-times-per-day dosage requirement. The contract, valued at $13,040.76, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which provides a comprehensive range...